Aripiprazole Improves Depressive Symptoms and Immunological Response to Antiretroviral Therapy in an HIV-Infected Subject with Resistant Depression

Aripiprazole is the first medication approved by the FDA as an add-on treatment for MDD. The impact of aripiprazole on the response to HIV is unknown. The patient we report on was diagnosed HIV-positive in 1997 and has been treated with antiretroviral therapy since then. In 2008, we diagnosed resist...

Descripción completa

Detalles Bibliográficos
Autores principales: Cecchelli, Chiara, Grassi, Giacomo, Pallanti, Stefano
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847761/
https://www.ncbi.nlm.nih.gov/pubmed/20369069
http://dx.doi.org/10.1155/2010/836214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847761/
https://www.ncbi.nlm.nih.gov/pubmed/20369069
http://dx.doi.org/10.1155/2010/836214

Ejemplares similares